Search tips
Search criteria 


Logo of molmedLink to Publisher's site
Mol Med. 1997 June; 3(6): 397–402.
PMCID: PMC2230203

HLA-H and associated proteins in patients with hemochromatosis.


BACKGROUND: The 845A(C282Y) mutation in the HLA-H gene accounts for most cases of hereditary hemochromatosis in patients who are of European origin. Some lack this mutation, however, and it is not present in Asian patients. Thus, other mutations either in HLA-H or associated proteins may be present in such patients. HLA-H associates with beta-2-microglobulin. Calreticulin associates with class 1 HLA proteins and appears to be identical with mobilferrin, a putative iron transport protein. These two proteins are therefore candidates for mutations in patients with hemochromatosis. MATERIALS AND METHODS: We have sequenced the coding region and parts of introns of the HLA-H gene, the beta-2-microglobulin gene, and the calreticulin (mobilferrin) gene of 10, 7, and 5 hemochromatosis patients, respectively, selecting those who were not homozygous for the 845A(C282Y) mutation. The number of chromosomes at risk studied were 18 for HLA-H, 14 for beta-2-microglobulin and 10 for calreticulin. RESULTS: We detected 3 new intronic polymorphisms in the HLA-H gene, each a point mutation. Some differences from published sequences of beta-2-microglobulin and calreticulin were documented, but these were uniformly present in all samples. CONCLUSIONS: The lack of additional mutations in the HLA-H gene is remarkable, and we speculate that the C282Y mutation may be a gain-of-function change.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (730K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Simon M, Pawlotsky Y, Bourel M, Fauchet R, Genetet B. Hémochromatose idiopathique Maladie associée à l'antigène tissulaire HL-A 3. Nouv Presse Med. 1975 May 10;4(19):1432–1432. [PubMed]
  • Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Jr, Ellis MC, Fullan A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399–408. [PubMed]
  • Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, Pockros P, Kosty M, Venditti CP, Phatak PD, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 1996;22(2):187–194b. [PubMed]
  • Santos M, Schilham MW, Rademakers LH, Marx JJ, de Sousa M, Clevers H. Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med. 1996 Nov 1;184(5):1975–1985. [PMC free article] [PubMed]
  • Rothenberg BE, Voland JR. beta2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1529–1534. [PubMed]
  • Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity. 1996 Aug;5(2):103–114. [PubMed]
  • Conrad ME, Umbreit JN, Moore EG. Rat duodenal iron-binding protein mobilferrin is a homologue of calreticulin. Gastroenterology. 1993 Jun;104(6):1700–1704. [PubMed]
  • Sferra TJ, Collins FS. The molecular biology of cystic fibrosis. Annu Rev Med. 1993;44:133–144. [PubMed]
  • Shore S, Tomczak J, Grebner EE, Myerowitz R. An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease. Hum Mutat. 1992;1(6):486–490. [PubMed]
  • Mahuran DJ. Beta-hexosaminidase: biosynthesis and processing of the normal enzyme, and identification of mutations causing Jewish Tay-Sachs disease. Clin Biochem. 1995 Apr;28(2):101–106. [PubMed]
  • Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med. 1996 Dec 12;335(24):1799–1805. [PubMed]
  • Powell LW, Jazwinska EC. Hemochromatosis in heterozygotes. N Engl J Med. 1996 Dec 12;335(24):1837–1839. [PubMed]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ